Identification of Possible Trigeminal Neuralgia
IDTN
Validating a Questionnaire for the Identification of Possible Trigeminal Neuralgia in Dental Practice
3 other identifiers
observational
250
1 country
1
Brief Summary
Trigeminal neuralgia (TN) is a severe type of non-dental orofacial pain that can feel like sudden electric shocks in the face and is often mistaken for tooth pain or other dental problems. This can lead to delays in referral and unnecessary, sometimes irreversible, dental treatment. The goal of this observational study is to evaluate how well a new questionnaire (IDentification of possible Trigeminal Neuralgia - IDTN) identifies adults with possible trigeminal neuralgia among patients attending hospital clinics with orofacial pain, with the aim of supporting its use in dental and general medical practice to improve early recognition and referral. The main questions it aims to answer are:
- How accurately does the IDTN questionnaire identify patients with possible trigeminal neuralgia compared with the specialist clinical diagnosis?
- Which combination of questionnaire items best supports a practical screening score for use in dental and/or general medical practice? Participants will:
- Complete the IDTN questionnaire before their clinical appointment (either electronically or on paper)
- Undergo their usual specialist clinical assessment, during which the final diagnosis will be recorded
- Allow the research team to compare questionnaire responses with the specialist diagnosis (the reference standard)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2026
CompletedFirst Posted
Study publicly available on registry
March 6, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
March 23, 2026
March 1, 2026
1 year
February 24, 2026
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic Accuracy of the IDTN Questionnaire
Sensitivity and specificity of the IDTN screening tool for identifying possible trigeminal neuralgia (TN), using the specialist clinical diagnosis as the reference standard. This will assess how accurately the questionnaire distinguishes between participants with and without possible TN.
Day 1 (at the participant's clinic appointment)
Secondary Outcomes (6)
Positive and Negative Predictive Values
Day 1
Receiver operating characteristic (ROC) curve and area under the curve (AUC)
Day 1
Internal Consistency Reliability
Through study completion (after all questionnaires are collected) (average 1 year)
Test - Retest Reliability
2-3 days after initial questionnaire completion
Validity
Day 1
- +1 more secondary outcomes
Study Arms (1)
Adults With Orofacial Pain
Adults aged 18 years or older attending the University COllege London Hospital (UCLH) Facial Pain Service or the Oral Surgery Clinic for their first appointment for facial or oral pain. All participants will complete the IDTN questionnaire before their routine clinical consultation. Their specialist diagnosis (for example, trigeminal neuralgia or other facial/oral pain condition) will be used as the reference standard to assess the accuracy of the questionnaire.
Interventions
There are no interventions because this is an observational validation study. Participants complete a 15-item trigeminal neuralgia screening questionnaire (IDTN) before their clinical appointment.
Eligibility Criteria
Participants will be recruited from two clinical settings at University College London Hospitals (UCLH): the Facial Pain Service and the Oral Surgery Clinic. Eligible participants will be identified using clinic codes that indicate first-time attendance for pain-related referrals from primary care. This population includes individuals referred from primary care because of facial pain, dental pain, or suspected orofacial pain conditions, including trigeminal neuralgia.
You may qualify if:
- Adults aged 18 years or older
- Attending the UCLH Facial Pain Service or Oral Surgery Clinic for their first appointment for facial or oral pain following referral from primary care
You may not qualify if:
- Not experiencing facial or oral pain
- Unable to understand English well enough to complete the questionnaire
- Lacking capacity to provide informed consent
- Insufficient time before their appointment to read the information sheet, provide consent, and complete the questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University College, Londonlead
- British Pain Societycollaborator
Study Sites (1)
University College London Hospitals NHS Foundation Trust (UCLH) - Eastman Dental Hospital
London, UK, United Kingdom
Related Publications (7)
Jafree DJ, Zakrzewska JM, Bhatia S, Venda Nova C. Accuracy of the painDETECT screening questionnaire for detection of neuropathic components in hospital-based patients with orofacial pain: a prospective cohort study. J Headache Pain. 2018 Nov 6;19(1):103. doi: 10.1186/s10194-018-0932-5.
PMID: 30400770BACKGROUNDTeshima T, Zakrzewska JM, Potter R. A systematic review of screening diagnostic tools for trigeminal neuralgia. Br J Pain. 2023 Jun;17(3):255-266. doi: 10.1177/20494637221146854. Epub 2023 Jan 2.
PMID: 37342400BACKGROUNDHadlaq EM, Khan H, Mubayrik AB, Almuflehi NS, Mawardi H. Dentists' knowledge of chronic orofacial pain. Niger J Clin Pract. 2019 Oct;22(10):1365-1371. doi: 10.4103/njcp.njcp_110_19.
PMID: 31607725BACKGROUNDvon Eckardstein KL, Keil M, Rohde V. Unnecessary dental procedures as a consequence of trigeminal neuralgia. Neurosurg Rev. 2015 Apr;38(2):355-60; discussion 360. doi: 10.1007/s10143-014-0591-1. Epub 2014 Nov 25.
PMID: 25418511BACKGROUNDCruccu G, Finnerup NB, Jensen TS, Scholz J, Sindou M, Svensson P, Treede RD, Zakrzewska JM, Nurmikko T. Trigeminal neuralgia: New classification and diagnostic grading for practice and research. Neurology. 2016 Jul 12;87(2):220-8. doi: 10.1212/WNL.0000000000002840. Epub 2016 Jun 15.
PMID: 27306631BACKGROUNDZakrzewska JM, Wu J, Mon-Williams M, Phillips N, Pavitt SH. Evaluating the impact of trigeminal neuralgia. Pain. 2017 Jun;158(6):1166-1174. doi: 10.1097/j.pain.0000000000000853.
PMID: 28114183BACKGROUNDAllsop MJ, Twiddy M, Grant H, Czoski-Murray C, Mon-Williams M, Mushtaq F, Phillips N, Zakrzewska JM, Pavitt S. Diagnosis, medication, and surgical management for patients with trigeminal neuralgia: a qualitative study. Acta Neurochir (Wien). 2015 Nov;157(11):1925-33. doi: 10.1007/s00701-015-2515-4. Epub 2015 Sep 2.
PMID: 26329729BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Joanna M Zakrzewska
University College London (UCL) and University College London Hospitals NHS Foundation Trust (UCLH)
- PRINCIPAL INVESTIGATOR
Nikolaos Apostolidis
University College London Hospitals NHS Foundation Trust (UCLH) and University College London (UCL)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2026
First Posted
March 6, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
May 1, 2027
Last Updated
March 23, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Anonymized IPD and supporting materials will be available 6 months after publication of the main study results and will remain available for up to 5 years thereafter.
- Access Criteria
- Access will be provided to qualified researchers for scientifically justified purposes. Requests must be submitted in writing to the Chief Investigator and will be reviewed jointly by the research team and sponsor (UCL). Approved researchers will sign a data sharing agreement and will receive access to anonymized datasets through a secure transfer mechanism.
Fully anonymized individual participant data (IPD) that underlie the published results will be shared. This will include anonymized responses to the IDTN questionnaire, demographic variables (such as age and gender), and the final clinical diagnosis used as the reference standard. All direct identifiers will be removed, and data will be de-identified according to UCL/UCLH (University College London/University College London Hospitals) data governance requirements before sharing.